Gilead Ties Up With 4 Indian Companies To Manufacture Remdesivir

Gilead Sciences has tied up with 4 Indian companies and 1 Pakistani pharmaceutical company to expand the supply of the drug remdesivir to 127 countries. 

The Indian companies are Jubilant Life Sciences, Cipla, Hetero Labs, and Mylan while the Pakistani company is Ferozsons Laboratories. These companies will set their own prices for the generic products they produce. These licenses are royalty free until the World Health Organization declares the end of the public health emergency or till another drug or vaccine is approved to treat COVID-19.